Anti-TTC19/ 2010204O13Rik/ MC3DN2 functional antibody

Anti-TTC19/ 2010204O13Rik/ MC3DN2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to TTC19/TTC19 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1401-Ab-1/ GM-Tg-hg-SE1401-Ab-2Anti-Human TTC19 monoclonal antibodyHuman
GM-Tg-rg-SE1401-Ab-1/ GM-Tg-rg-SE1401-Ab-2Anti-Rat TTC19 monoclonal antibodyRat
GM-Tg-mg-SE1401-Ab-1/ GM-Tg-mg-SE1401-Ab-2Anti-Mouse TTC19 monoclonal antibodyMouse
GM-Tg-cynog-SE1401-Ab-1/ GM-Tg-cynog-SE1401-Ab-2Anti-Cynomolgus/ Rhesus macaque TTC19 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1401-Ab-1/ GM-Tg-felg-SE1401-Ab-2Anti-Feline TTC19 monoclonal antibodyFeline
GM-Tg-cang-SE1401-Ab-1/ GM-Tg-cang-SE1401-Ab-2Anti-Canine TTC19 monoclonal antibodyCanine
GM-Tg-bovg-SE1401-Ab-1/ GM-Tg-bovg-SE1401-Ab-2Anti-Bovine TTC19 monoclonal antibodyBovine
GM-Tg-equg-SE1401-Ab-1/ GM-Tg-equg-SE1401-Ab-2Anti-Equine TTC19 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1401-Ab-1/ GM-Tg-hg-SE1401-Ab-2; GM-Tg-rg-SE1401-Ab-1/ GM-Tg-rg-SE1401-Ab-2;
GM-Tg-mg-SE1401-Ab-1/ GM-Tg-mg-SE1401-Ab-2; GM-Tg-cynog-SE1401-Ab-1/ GM-Tg-cynog-SE1401-Ab-2;
GM-Tg-felg-SE1401-Ab-1/ GM-Tg-felg-SE1401-Ab-2; GM-Tg-cang-SE1401-Ab-1/ GM-Tg-cang-SE1401-Ab-2;
GM-Tg-bovg-SE1401-Ab-1/ GM-Tg-bovg-SE1401-Ab-2; GM-Tg-equg-SE1401-Ab-1/ GM-Tg-equg-SE1401-Ab-2
Products NameAnti-TTC19 monoclonal antibody
Formatmab
Target NameTTC19
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TTC19 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1401-Ag-1Recombinant multi-species TTC19/ 2010204O13Rik/ MC3DN2 protein


    Target information

    Target IDGM-SE1401
    Target NameTTC19
    Gene ID54902,72795,691506,700653,479516,101083219,789903,100073148
    Gene Symbol and Synonyms2010204O13Rik,2810460C24Rik,MC3DN2,RGD1311797,TTC19
    Uniprot AccessionQ6DKK2,D4A6D7
    Uniprot Entry NameTTC19_HUMAN,TTC19_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000011295
    Target ClassificationN/A

    The target: TTC19, gene name: TTC19, also named as 2010204O13Rik, MC3DN2. This gene encodes a protein with a tetratricopeptide repeat (TPR) domain containing several TPRs of about 34 aa each. These repeats are found in a variety of organisms including bacteria, fungi and plants, and are involved in a variety of functions including protein-protein interactions. This protein is embedded in the inner mitochondrial membrane and is involved in the formation of the mitochondrial respiratory chain III. It has also been suggested that this protein plays a role in cytokinesis. Mutations in this gene cause mitochondrial complex III deficiency. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.